New Clinical Payment Policy Effective September 1, 2026 - Drugs of Abuse: Definitive Testing for more than 14 Drugs/Drug Classes
Date: 06/09/26
Superior HealthPlan and Ambetter Health (Ambetter from Superior HealthPlan and Ambetter Health Solutions) present a new payment policy. The following policy is posted on Superior’s Clinical, Payment and Pharmacy Policies webpage for review, prior to its implementation.
POLICY | EFFECTIVE DATE | APPLICABLE PRODUCTS | NEW POLICY OVERVIEW OR UPDATED POLICY REVISIONS |
Clinical Policy: Drugs of Abuse: Definitive Testing for more than 14 Drugs/Drug Classes (TX.CP.MP.50-A) | September 1, 2026 | Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP), | It is the policy of Centene Advanced Behavioral Health and the Texas health plans affiliated with Centene Corporation that outpatient confirmatory/definitive (quantitative) drug testing of more than 14 drugs/drug classes is not medically necessary. |
To review all clinical payment or payment policies, please visit Superior’s Clinical, Payment and Pharmacy Polices webpage.
For questions or additional information, please contact your Provider Representative. To access their contact information visit Find My Provider Representative